Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Astrocytoma × trametinib × Clear all

Phase

Status

Completed 2 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Carcinoma, Anaplastic 3 Melanoma 3 Glioma 3 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Solid Tumor Cancer 1 Solid Tumor 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Rare Malignant Neoplasm 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 1 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Locally Advanced Thyroid Gland Carcinoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia 1 Hematologic Neoplasms 1 Eunuchism 1 Erectile Dysfunction 1

Interventions

Temozolomide 9 Radiotherapy 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Bevacizumab 3 Radiation 2 Genetic Therapy 2 Fluorodeoxyglucose F18 2 vorasidenib 1 trastuzumab deruxtecan 1 trametinib 1 ribociclib 1 regorafenib 1 pembrolizumab 1 olutasidenib 1 lorlatinib 1 aflibercept 1 abexinostat 1 Vinblastine 1 Tretinoin 1 Therapies, Investigational 1 Surgical Procedures, Operative 1 Restraint, Physical 1 Re-Irradiation 1 Radiotherapy, Intensity-Modulated 1 Pluvicto 1 Paclitaxel 1 Oncolytic Virotherapy 1 ONC206 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05180825 2025-08-08

PLGG - MEKTRIC

University Hospital, Strasbourg, France

Phase 2 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡